Blocking of the PD-1/PD-L1 signaling pathway has been shown to reinvigorate exhausted CD8+ T cells in both tumor and chronic viral infections, thereby restoring their cytotoxic capabilities (12, 14, 18, 19). The gene discussed is CD8A; the disease is neoplasm.